Judith F. Krandel's most recent trade in Nephros Inc was a trade of 68,861 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on March 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nephros Inc | Judith F. Krandel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.71 per share. | 23 Mar 2026 | 68,861 | 68,861 (0%) | 0% | 1.7 | 117,752 | Common Stock |
| Nephros Inc | Judith F. Krandel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2026 | 68,861 | 53,663 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Judith F. Krandel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2026 | 4,000 | 4,000 | - | - | Stock Option (right to buy) | |
| Beam Global | Judith F. Krandel | Director | Grant, award, or other acquisition of securities at price $ 1.75 per share. | 06 Jan 2026 | 71,577 | 133,019 (2%) | 1% | 1.8 | 125,260 | Common Stock |
| Nephros Inc | Judith F. Krandel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 54,359 | 54,359 | - | - | Stock Option (right to buy) | |
| Beam Global | Judith F. Krandel | Director | Grant, award, or other acquisition of securities at price $ 3.09 per share. | 02 Jan 2025 | 40,453 | 61,443 (1%) | 0% | 3.1 | 125,000 | Common Stock |